CR_OMB Supporting Statement B 100903 clean

CR_OMB Supporting Statement B 100903 clean.pdf

Parts C and D Complaints Resolution Performance Measures

OMB: 0938-1107

Document [pdf]
Download: pdf | pdf
Part C and D Complaints Resolution Performance Measure
CMS-10308

OMB Supporting Statement – Part B
September 3, 2010

Contents
Collection of Information Involving Statistical Methods ........................................................ 1
1. Respondent Universe and Sampling ............................................................................. 1
2. Procedures for the Collection of Information ............................................................... 8
3. Methods to Maximize Response Rates and Data Reliability ..................................... 13
4. Tests of Procedures or Methods ................................................................................. 14
5. Individuals Consulted on Statistical Methods ............................................................ 17

Page i

Collection of Information Involving Statistical Methods
1. Respondent Universe and Sampling
CMS is interested in gathering information to determine the possibility of developing
performance measures associated with beneficiaries’ satisfaction with the complaints resolution
process. This effort will emphasize that the measures are developed separately for each contract.
The survey population is made up of beneficiaries with closed urgent or immediate need
complaints that were filed against their respective contracts during the period covering the
months of January and February 2011. This data collection period was chosen because CMS is
interested in the months with the largest number of complaints in order to achieve the most
statistically valid sample. All Medicare Advantage and Prescription Drug contracts will be
surveyed regardless of their enrollment size, and the sampling will be carried out from the
Complaints Tracking Module (CTM) database. However, members of 800 series contracts will
be excluded from selection. 800 series contracts are MA Organizations, PDP sponsors, and
Section 1876 Cost Plan Sponsors that offer, sponsor, or administer certain types of employer
sponsored group contracts (employer/union-only group waiver contracts also referred to as
EGWPs). Not only in this case, but also in many other situations, CMS excludes EGWPs as they
are overseen differently than other contracts. Additionally, if the data collected from this effort is
used for the development of a performance rating, CMS does not currently post performance
ratings for EGWPs. This is primarily because these contracts are not open to the public but only
to the relevant employer/union organization members.
This survey will collect data about beneficiaries’ experience with the contract sponsor complaint
resolution processes and the effectiveness of the resolution (a discussion of the indicators and
preliminary measures from the survey instrument is included in Supporting Statement A, section
B.16.a. Tabulations). The use of a short recall period will allow beneficiaries to have the best
possible recollection of their experiences. The sampling of complaints will be carried out from
the CTM database every week on a flow basis as they are closed. The data collection period will
allow for a waiting period of 7 days for CMS and contract records to be updated and attempts to
communicate with the beneficiary to be completed.
To ensure a good representation of the complaint population, a total sample of 6,500 complaints
will be allocated across weeks, proportionally to the expected weekly count of closed
complaints. This total sample size of 6,500 was determined based on precision requirements and
budgetary constraints, as discussed below in subsection 2.a. The sampling strategy will exclude
complaints that are outside of the scope of the contract, particularly some complaints related to
enrollment issues (e.g., when a beneficiary enrolled after the deadline for enrollment). Further
review of the complaints will take into consideration that there are certain actions that may have
been within CMS guidelines but required further actions from agents other than the contract and
these may have caused dissatisfaction on the part of the beneficiary (e.g., involvement by the
Retro Processor Contract, which adds several days to a resolution.)
IMPAQ International, LLC

1

OMB Supporting Statement

CMS will collect information on all contracts (except for 800 series) including those contracts
with small enrollment and/or with a small number of complaints. CMS is interested in
developing preliminary measures that can be calculated for all contracts. For this purpose, all
contracts will be included in the data collection, and CMS will determine later what strategies
will be used to address small samples and limited information.
The 2011 survey population is unknown at the present time and will remain unknown until the
end of the survey, due to the rolling sampling approach adopted to minimize recall bias. For the
purpose of designing the sampling, we used 2008 and 2009 CTM data for the period spanning
January 1 through March 4. Although the 2011 complaint counts are expected to be different
from those of 2008 and 2009, we expect the overall 2011 weekly distribution of closed
complaints—all contracts combined—to have the same pattern as was observed in 2008 and
2009. That is, the highest volume of closed complaints is expected to be observed in the second
week of collection, with a gradual decrease thereafter. The CMS staff supports this assumption,
and available data on complaints for the first quarter of 2010 provide supporting evidence for
this argument. Table B.1.a. shows the weekly distribution of complaints closed each week,
based on 2008, 2009, 2010 CTM data for the period from January 1 through March 4. The
weekly distribution of complaints includes only those complaints that were closed during the
week.
Table B.1.a. shows that while 12,392 complaints filed against 499 contracts were closed during
the first 9 weeks of 2010, a total of 19,801 complaints filed against 541 contracts were closed
during the same period in 2009. The weekly proportions of complaints in these 3 years remain
very similar, with week 2 holding the highest number of complaints closed (21% in 2010, 16% in
2009, and 20% in 2008). Starting in week 3 these percentages decrease gradually through week
9. This distribution is expected to vary substantially from one contract to another, with some
small contracts having no more than one closed complaint. Table B.1.b. demonstrates a nearly
consistent distribution of complaints by complaint categories in the first nine weeks of the year.
Table B.1.c. presents the distribution over 12 months, which, when compared to Table B.1.b.,
shows that the distribution of the project sample is close to the distribution of complaints over
the year.
The data collection period was selected primarily for the expected high complaint volume during
the first three months of the calendar year as beneficiaries and contracts work out
benefits/services and operational issues. CMS expects that contracts are efficient in resolving
enrollment and other immediate issues and, thus, the complaints topics are better examined
during this time. Complaints issues encountered later on during the calendar year are also
captured in the first quarter of the contract year, therefore there is only a moderate bias in the
included complaint types and numbers. CMS will note in its results the period of data collection
to limit the representativeness of the selected complaints and prevent confusion over
generalizations to the entire contract year.
IMPAQ International, LLC

2

OMB Supporting Statement

This time period was also selected to provide flexibility for analysis and production of
performance measures (if CMS chooses to do so) per contract by mid-July. This timeline would
allow time for CMS to produce the performance star rating and post online by mid-September
for beneficiary reference in their selection of Parts C and D contracts.

IMPAQ International, LLC

3

OMB Supporting Statement

Table B.1.a. Distribution of Complaints by Year and Week for the First 9 Weeks of the Year
Number of Complaints
Year

Number of Contracts

WK 1

WK 2

WK 3

WK 4

WK 5

WK 6

WK 7

WK 8

WK 9

Total

2010

499

845

2,572

1,544

1,477

1,395

1,367

1,107

1,065

1,021

12,392

2009

541

1,492

3,183

2,443

2,276

2,166

2,524

2,060

1,864

1,792

19,801

2008

470

2,340

6,402

5,816

4,798

3,932

2,741

2,148

1,702

1,701

31,580

Proportion
2010

7%

21%

13%

12%

11%

11%

9%

9%

8%

100%

2009

8%

16%

12%

11%

11%

13%

10%

9%

9%

100%

2008

7%

20%

18%

15%

12%

9%

7%

5%

5%

100%

IMPAQ International, LLC

4

OMB Supporting Statement

Table B.1.b. Distribution of Complaints by Week (the first 9 weeks) and Category (2008-2010)
% Total
% Wk 1 % Wk 2 % Wk 3 % Wk 4 % Wk 5 % Wk 6
Volume
Enrollment/Disenrollment
2010
6920
55.8%
50.7%
52.2%
58.7%
55.7%
58.8%
57.7%
Pricing/Co-Insurance
2010
1753
14.1%
10.5%
12.1%
14.6%
16.6%
15.4%
15.2%
Benefits/Access
2010
1287
10.4%
13.0%
9.5%
11.3%
10.6%
10.5%
9.8%
Plan Administration
2010
812
6.6%
16.4%
16.4%
3.6%
3.4%
2.5%
2.5%
Formulary
2010
650
5.2%
4.4%
4.0%
4.7%
5.0%
5.6%
5.9%
Exceptions/Appeals
2010
269
2.2%
1.1%
1.4%
1.4%
2.0%
1.6%
2.7%
Customer Service
2010
254
2.0%
2.1%
1.9%
1.7%
2.3%
2.2%
1.8%
Marketing
2010
224
1.8%
0.5%
0.8%
2.0%
2.4%
2.1%
1.8%
Other
2010
223
1.7%
1.3%
1.6%
2.0%
2.0%
1.2%
2.5%
Total
2010
12392
12392
845
2572
1544
1476
1395
1367
Enrollment/Disenrollment
2009
11989
60.5%
62.5%
62.1%
59.7%
60.3%
59.4%
63.4%
Benefits/Access
2009
2488
12.6%
15.8%
14.6%
14.3%
12.7%
11.7%
10.6%
Pricing/Co-Insurance
2009
2454
12.4%
10.3%
11.7%
13.1%
12.7%
13.7%
11.6%
Formulary
2009
899
4.5%
2.9%
2.7%
4.2%
4.5%
5.0%
4.6%
Plan Administration
2009
781
3.9%
4.2%
4.4%
3.2%
4.7%
3.6%
4.0%
Customer Service
2009
395
2.0%
1.9%
1.8%
2.1%
2.2%
2.2%
1.6%
Exceptions/Appeals
2009
287
1.4%
0.9%
0.7%
1.4%
0.9%
1.3%
1.3%
Marketing
2009
233
1.2%
0.7%
0.6%
0.8%
1.0%
1.6%
1.4%
Other
2009
275
1.3%
0.8%
1.3%
1.2%
1.0%
1.4%
1.4%
Total
2009
19801
19801
1492
3183
2443
2276
2166
2524
Enrollment/Disenrollment
2008
20774
65.8%
63.2%
68.9%
64.7%
64.8%
65.0%
66.5%
Pricing/Co-Insurance
2008
4346
13.8%
16.8%
12.8%
15.4%
14.1%
13.2%
13.4%
Benefits/Access
2008
2503
7.9%
9.3%
9.0%
7.5%
7.3%
8.1%
7.2%
Formulary
2008
1388
4.4%
3.0%
3.2%
3.5%
5.2%
4.8%
4.9%
Customer Service
2008
1203
3.8%
4.6%
2.8%
3.8%
4.2%
4.2%
3.8%
Plan Administration
2008
504
1.6%
1.4%
1.5%
2.0%
1.8%
1.5%
1.2%
Grievances
2008
326
1.0%
0.4%
0.7%
1.4%
0.7%
1.5%
1.2%
Exceptions/Appeals
2008
272
0.9%
0.5%
0.3%
1.0%
1.0%
0.9%
1.0%
Other
2008
264
0.8%
0.8%
0.7%
0.4%
1.0%
1.0%
0.9%
Total
2008
31580
31580
2340
6402
5816
4798
3932
2741
Note: the first 8 major categories are listed and the rest are represented by ―other.‖ Percentages are based on column totals.

Complaint Category

IMPAQ International, LLC

Year

Total

5

% Wk 7

% Wk 8

% Wk 9

56.8%
14.4%
10.1%
2.9%
6.9%
2.8%
2.1%
2.3%
1.8%
1107
60.0%
11.1%
12.9%
5.4%
3.7%
1.7%
2.0%
1.5%
1.7%
2061
66.6%
12.3%
7.4%
5.7%
3.4%
1.5%
1.2%
0.9%
1.0%
2148

56.8%
14.8%
10.0%
2.1%
5.7%
3.8%
2.0%
2.7%
2.1%
1065
58.2%
10.2%
12.6%
6.8%
3.6%
2.6%
2.3%
1.9%
1.9%
1864
65.2%
12.1%
7.4%
6.0%
4.4%
1.2%
1.0%
1.2%
1.6%
1702

56.5%
13.8%
10.2%
2.2%
6.7%
3.9%
2.5%
2.4%
1.8%
1021
58.0%
11.7%
12.7%
5.8%
4.0%
2.1%
2.8%
1.4%
1.6%
1792
64.3%
11.9%
7.1%
6.6%
4.7%
1.8%
1.1%
1.5%
0.9%
1701

OMB Supporting Statement

Table B.1.c. Distribution of Complaints by Month and Category (2009)
%
%
%
%
%
%
%
%
Month Month Month Month Month Month Month Month
1
2
3
4
5
6
7
8
Enrollment/Disenrollment
36999
60.8% 60.3% 60.1% 64.8% 63.2% 61.0% 57.4% 54.9%
Benefits/Access
7708
13.9% 11.0% 9.8%
10.0% 10.1% 12.6% 15.1% 15.8%
Pricing/Co-Insurance
7696
12.4% 12.3% 12.4% 10.5% 11.5% 11.3% 12.0% 14.2%
Formulary
3142
3.8%
5.4%
6.4%
4.7%
4.9%
5.2%
4.8%
5.1%
Plan Administration
1963
4.1%
3.9%
3.8%
2.4%
2.6%
2.4%
2.6%
1.9%
Customer Service
1250
2.0%
2.0%
1.9%
1.8%
2.0%
1.8%
2.0%
2.3%
Exceptions/Appeals
1241
1.0%
1.9%
2.3%
2.0%
2.2%
2.4%
2.1%
2.1%
Marketing
792
0.8%
1.6%
1.6%
1.8%
1.3%
1.2%
1.4%
1.0%
other
10050
1.1%
1.5%
1.5%
2.0%
2.2%
2.0%
2.4%
2.7%
Total
61982
10387 8480
7749
7608
5790
4863
4133
3189
Note: the first 8 major categories are listed and the rest are represented by ―other.‖ Percentages are based on column totals.
Complaint Category

IMPAQ International, LLC

Total

%
Total
Volume
59.7%
12.4%
12.4%
5.1%
3.2%
2.0%
2.0%
1.3%
1.9%

6

%
Month
9
53.3%
15.0%
14.4%
6.3%
2.7%
1.8%
2.6%
1.4%
2.4%
2841

%
Month
10
53.2%
15.1%
14.6%
5.6%
2.9%
2.1%
2.9%
0.6%
2.9%
2586

%
Month
11
54.7%
14.7%
13.4%
5.8%
3.1%
2.4%
2.2%
0.9%
2.5%
2008

%
Month
12
52.7%
15.9%
16.1%
4.2%
3.3%
2.7%
2.6%
0.6%
2.0%
2348

OMB Supporting Statement

The recommended sampling approach is described as follows:
The total number of sample complaints to be selected for all contracts under investigation
is 6,500. This overall 2011 sample size will be allocated across the 9 weeks of the survey
implementation as shown in Table B.2. This allocation is based on the weekly 2008–
2009 average proportion of closed complaints. In week 1 of the year 2011, for example,
520 complaints will be sampled, while week 2 will provide 1,170 of the total 6,500
sample complaints. The last sampling phase will occur in week 9 with the selection of a
total of 455 complaints from all contracts. An analysis of 2009 CTM data has
demonstrated that an overall sample size of 6,500 is sufficient to achieve for each
contract an error margin of 10% for a minimum confidence level of 85%. Moreover, the
proposed allocation ensures a weekly sampling fraction (i.e., the ratio of the sample size
to the 2009 population size) that varies from 24% to 40%. 2010 data confirm these
sampling estimates.
In 2011, the final number of complaints to be selected from each contract in any given
week will be determined at the time of sampling on the basis of the actual observed
counts. This will be achieved by allocating the predetermined overall weekly sample of
Table B.2 across contracts, proportionally to the square root of the observed counts of
complaints. The complaint sample weekly allocation to contracts is carried out
proportionally to the square root of the observed complaint counts, as opposed to the
plain counts, to avoid an underrepresentation of contracts with a small number of
complaints. Each contract must be well represented in the total sample since
performance measures will be calculated individually for each contract.
In week 1 for example, the number of sample complaints
particular contract is calculated as follows:

to be selected from a

where
is the predetermined number of complaints to sample in week 1 for all
contracts,
is the observed number of complaints filed against contract in
week 1, and is the number contracts with at least one complaint in week 1.
The square root rule will provide an initial allocation of the weekly complaint sample
across contracts in 2011. This allocation will eventually be adjusted, primarily to
increase the sample size in small contracts or decrease that of large contracts so as to
meet the precision objectives for all contracts. Since the total number of complaints filed
against a contract will not be known until after week 9, the achieved error margin will be
monitored each week from week 3 and will be used to eventually adjust the weekly
sample size as needed.
IMPAQ International, LLC

7

OMB Supporting Statement

Postponing the sample size determination at the contract level to 2011 is due to the
difficulty of predicting the actual 2011 counts of complaints with any reliability. In the
next section, we will discuss the precision level that we anticipate with the current
sampling strategy.
Table B.2: Allocation of the 2011 Complaint Sample Across Weeks
Week
Allocation of the 2011
Complaint Sample
Weekly Proportions of
2011 Sample Complaints
(2008-2009 Avg.
Proportions)

Wk
1

Wk
2

Wk
3

Wk
4

Wk
5

Wk
6

Wk
7

Wk
8

Wk Total
9

520

1,170

975

845

780

715

585

455

455

6,500

8%

18%

15% 13% 12% 11%

9%

7%

7%

100%

Since the actual number of complaints is unknown until the end of the survey (March 4, 2011).
The sample size of 6,500 is estimated based on the observed number of closed complaints
between January 1, 2009 and March 4, 2009. Specifically, it was estimated through the following
steps:





Obtain the population size (total number of complaints closed during Jan 1-March 4
excluding uninterested complaints such as complaints from provider, non urgent and
immediate etc) for each contractor
Estimate the required sample size based on population size, required precision level
(error of margin as 0.10 and confidence level as 85%), and estimated response rate (80%)
Sum the sample size over all contracts that have at least one complaint.

A proactive sampling design has been developed to minimize low response rates or oversample
contracts with a small number of complaints. Therefore, we may achieve confidence intervals of
95% for some contracts and an 85% confidence interval for all contracts. After the completion of
the first full-scale data collection, CMS may choose to revisit and increase the confidence
interval for future data collection efforts.
Table B.3. below summarizes the distribution of contractor and complaints by complaint range.

IMPAQ International, LLC

8

OMB Supporting Statement

Table B.3: Distribution of Contracts and Complaints Count Range (2009)
Range of Complaint Count
0 – 19
Population
Size
Sample
Size

20 – 51

52 – 84

85+

TOTAL

Contracts

Complaints

Contracts

Complaints

Contracts

Complaints

Contracts

Complaints

Contracts

Complaints

436

2156

51

1557

19

1191

35

14897

541

19801

436

2156

79

2509

26

1711

0

0

541

6376

The sample size of 6,500 is rounded up from the estimated sample size of 6,376 to ensure a
sufficient sample size.
2. Procedures for the Collection of Information
a) Statistical Methodology, Estimation, and Degree of Accuracy
The primary objective of this survey is to collect data to determine the possibility of developing
performance indicators that measure the beneficiary’s satisfaction with the complaint’s final
outcome and complaint process. The current study design is optimized for performance
measures that are expressed in the form of percentages. The sample size ( ) for each contract
will depend on the complaint population size ( ), the desired confidence level (CL), and the
error margin (E) associated with the performance measure. The three quantities , CL, and E are
interrelated in such a way that two of them must be known to determine the third. Therefore, our
desire to determine the sample size requires the knowledge of CL and E, which must be
hypothesized.
As indicated in section B.1, the disproportional distribution of complaints by week requires a
weekly selection of complaints with different selection probabilities. These differential selection
probabilities must be accounted for when quantifying the precision of performance measures.
The use of different selection probabilities will result in an increase in the variance associated
with survey statistics by a factor known as the Design Effect (DEFF). For a given value of
DEFF, the sample size for a particular contract is calculated as follows:

(z

n
1

(z

2

2 E ) 2 DEFF

2

2 E ) 2 DEFF 1

,

(B.2)

N
where
is the critical value representing the influence of the confidence level on the error
margin. The subscript
associated with the critical value
represents the lack of
confidence in the magnitude of the error margin (i.e., = 1 – Confidence Level) and is assigned
a small value during the study design.
Table B.4 shows the minimum sample size required by population size, and for various values of
the confidence level and the error margin. These estimated sample sizes are based on a
IMPAQ International, LLC

9

OMB Supporting Statement

hypothesized design effect of 1.2, which represents an increase of 20% of the variance due to the
complexity of the sample selection protocol. Design effects of 1.2 or less are common in many
statistical surveys that are based on complex samples. The 85%/10% column contains the
minimum sample size requirements that will be implemented.
Table B.5 shows the size of the initial sample required to obtain the minimum number of
respondents of Table B.4. The numbers in Table B54 are based upon the assumption of a
response rate situated around 80%, and give an indication of the number of complaints required
per contract in the sample to meet the specified precision requirements for different values of the
complaint population size. Using 2009 CTM data, we were able to determine that a total initial
sample size of 6,500 complaints allows us to guarantee, for each contract, a maximum error
margin of 10% and a minimum confidence level of 85%. To ensure a minimum confidence level
greater than 85% for the same error margin would require a sample size that is greater than
6,500.
The sample size of 6,500 could achieve a maximum error margin of 10% and a minimum
confidence level of 85% for each contract. The sample size is based on the total complaint
population of 19,801 and its observed distribution pattern among contracts. However, a ceiling
sample size of 6,500 will not be able to ensure the achievement of the same precision if there is
dramatic difference between 2011 and 2009 complaint data in terms of total complaint
population size or distribution patterns among contracts. For example, if the 2011 complaint
population size is significantly larger than 19,801, given the same distribution pattern, but the
sample size ceiling is set to 6,500, the achieved precision level will be lower than 85%/0.10.
Another possible scenario is that the complaint population size of 2011 could be similar to
19,801, but the distribution pattern could change (i.e., the number of contracts with low volume
complaints increases while the number of contracts with large volume complaints decreases).
This could also decrease the level of precision if the total sample size is set to 6,500. Last, the
level of precision would increase under a total sample size of 6,500 if the changes in the
population size and the distribution pattern are in the opposite direction.

IMPAQ International, LLC

10

OMB Supporting Statement

Table B. 4: Minimum Number of Respondents by Desired Confidence Levels and Error
Margins

Population Size

Desired
Confidence
Level
Target Error Margin
10
20
50
100
200
500
1,000
2,000
5,000
10,000
20,000
50,000

95%

90%

85%

80%

95%

90%

85%

80%

5%
10
20
46
83
140
241
316
375
423
441
451
457

5%
10
19
44
77
124
198
246
280
305
315
320
323

5%
10
19
42
72
112
167
200
222
237
243
246
248

5%
10
19
41
67
100
142
165
180
190
194
196
197

10%
10
18
36
54
74
94
104
110
113
114
115
115

10%
10
17
32
46
58
70
76
79
80
81
81
82

10%
9
16
28
39
48
56
59
61
62
62
62
63

10%
9
15
26
34
40
45
48
49
49
50
50
50

Table B. 5: Estimated Initial Sample Sizes Based on an 80% Response Rate

Population Size

Desired
Confidence
Level
Target Error Margin
10
20
50
100
200
500
1,000
2,000
5,000
10,000
20,000
50,000

95%

90%

85%

80%

95%

90%

85%

80%

5%
10
20
50
100
175
302
395
469
529
552

5%
10
20
50
97
155
248
308
350
382
394

5%
10
20
50
90
140
209
250
278
297
304

5%
10
20
50
84
125
178
207
225
238
243

10%
10
20
45
68
93
118
130
138
142
143

10%
10
20
40
58
73
88
95
99
100
102

10%
10
20
35
49
60
70
74
77
78
78

10%
10
19
33
43
50
57
60
62
62
63

564
572

400
404

308
310

245
247

144
144

102
103

78
79

63
63

The population size in tables B.4 and B.5 refer to the total number of complaints received during
the research time period per contractor. The sample size of a contractor then is determined based
on the population size, the desired precision level (both error margin and confidence level),
design effects as well as response rate, as displayed in table B3 and table B4.

IMPAQ International, LLC

11

OMB Supporting Statement

CMS has chosen to use a non-standard confidence interval of 85% due to budgetary constraints
since a 90% or 95% confidence interval will require a larger sample given the same error margin
and desired response rate (See Table B.6). This is in alignment with other CMS reported
monitoring and performance measures which are also calculated using an 85% confidence
interval. CMS may adjust the confidence interval target at a later time.
Table B.6: Required Sample Sizes per Desired Confidence Interval
Confidence Interval

Required Sample Size

80%

5831

85%

6376

90%

7092

95%

8097

Note: error margin=0.10 DEFF=1.2 Response rate=0.8

Another implication of the use of differential selection probabilities is the need to weight the
performance measures using weights obtained as the inverse of the complaint’s selection
probability. The beneficiary is the unit of analysis that should be weighted, and the complaint is
the sampling unit that receives the initial sampling weight. Therefore, the beneficiary weight
will be sum of the sampling weights of all complaints associated with the same beneficiary. If
is the number of beneficiaries in the sample, and the number of beneficiaries with a specific
characteristic of interest, the proportion of beneficiaries with the characteristic of interest is given
by:
m

p

b 1
M
b

where

wb

(B.3)

w
1 b

is the weight associated with beneficiary .
b) Unusual Problems Requiring Specialized Sampling Procedures

This survey will collect data about immediate-need complaints, which must be closed within 48
hours, and urgent complaints, which must be closed within 7 to 10 days. To account for the
delays needed by health contracts to close the complaints filed during a week, the weekly
sampling will select complaints filed during the 7-day period that ended 10 days prior to the
beginning of the sample selection. The last sample also would be selected 10 days after the last
week of February 2011. This delay in data collection would allow for allow time for
beneficiaries to receive notification of their complaint resolution or for data to be updated in the
electronic systems.
c) Periodic Cycles to Reduce Burden
We will implement the survey over a period of 2 months in order to collect data regarding
beneficiaries’ recent experience with their health contract’s complaint resolution process. The
IMPAQ International, LLC

12

OMB Supporting Statement

need for each interview to target one specific complaint makes a cyclical collection of data
unfeasible.
3. Methods to Maximize Response Rates and Data Reliability
a) Response Rates
We estimate an initial sample of 6,500 beneficiaries to result in 5,200 completed surveys (80%
response rate). To achieve this target, we will utilize a mixed-mode approach that utilizes
telephone as the primary mode of data collection, with mail follow-up. We believe that an 80%
response rate is achievable for three reasons: (1) this is a government-sponsored survey related to
Medicare; (2) we will be surveying a motivated population of people who have taken a stance
and filed a complaint by calling 1-800-Medicare; and (3) we are using a mixed-mode approach
that gives beneficiaries two options for participating in the survey. In addition to offering two
modes of completion, several other strategies will be used to achieve this high response rate.
First, before telephone interviewing begins, an advance letter describing the purpose and
sponsorship of the survey will be mailed to potential respondents (the letter is presented in
Appendix D). This advance letter will assure potential respondents that the caller is conducting a
research interview and not soliciting donations or selling anything. Letters will be sent
approximately one week before the sample is released to the phone survey scheduler. The letter
will provide a toll-free call-in number.
Second, experienced interviewers will be assigned to the study and extensively trained. These
interviewers will be thoroughly trained on data collection procedures, including methods for
promoting cooperation among sample members. Interviewers are skilled at encouraging
cooperation and will minimize the impact on responses resulting from the persuasion of reluctant
respondents.
Third, call scheduling in CATI will allow respondents to select the time most convenient for
them to be interviewed. We will make up to 10 attempts per complaint/beneficiary over a 3week period.
Fourth, beneficiaries who do not respond to the telephone survey by the 3-week mark will be
sent a paper copy of the questionnaire with a postage-paid return envelope.
Finally, a reminder postcard with a toll-free number will be sent to all nonrespondents
approximately one week after the hard copy mailing.
Although both approaches will be employed, the primary mode of data collection is intended to
be telephone administration. The 10 attempts to reach each beneficiary by phone and the 1-800
number provided to beneficiaries who receive mailed surveys both encourage phone

IMPAQ International, LLC

13

OMB Supporting Statement

participation in this data collection. Surveys will be mailed to telephone nonrespondents after a
period of calling through the CATI system.
b) Reliability of Data Collection
The beneficiary questionnaire was built on questionnaires developed for other studies, including
the CAHPS Hospital Survey and the CAHPS Health Plan Survey (Adult Medicaid
Questionnaire), both of which were reviewed and approved by OMB. Although the two CAHPS
surveys served as the original framework for the questionnaire, PDP Customer Service measures
were reflected in several questions. The J.D. Power and Associates ―2009 National Health
Insurance Plan Study‖ question topics regarding customer satisfaction were also incorporated.
The questions were designed to ensure that they would be easily understood by respondents.
Revisions were made to the draft questionnaire based on the results of the pretest, feedback
from CMS stakeholders, and public comments received from the publication of the 60-day
Federal Register Notice.
The use of computer-assisted telephone interviewing (CATI) to conduct the majority of
interviews will help to ensure the consistency of the data. CATI controls question branching
(reducing item nonresponse due to interviewer error), modifies wording (providing memory aids
and probes and personalizing questions), and constructs complex sequences that are not possible
to produce or are less accurate in hard-copy surveys. The probes, verifications, and consistency
checks are built into the system and standardize the procedures. These procedures ensure the
reliability of the data collection methods and the data collected through those methods. Issues
regarding the uniformity of surveys completed through the two modes of data collection are
detailed in Supporting Statement A (Section B.3. Use of Information Technology).
Last, IMPAQ International will monitor each interviewer’s work using silent call-monitoring
equipment and video monitors that display the interviewer’s screen.
4. Tests of Procedures or Methods
We propose to conduct two tests of procedures/methods for this survey:
Pre-Test: While OMB review was underway in March 2009, we tested the survey instrument
with a convenience sample of nine Medicare Part C and Part D beneficiaries. The pre-test design
was based on a cognitive interviewing model. The goal of the cognitive interviews was to test the
questionnaire content, ensure that the survey instructions and question wording are clear and
understandable, and that response options are adequate. The cognitive interviews allowed us to
determine the validity of the questions: Are respondents interpreting them as intended? Are the
questions measuring the constructs of interest? Questions that are misunderstood by respondents
or that are difficult to answer can be improved prior to fielding the main survey, thereby
increasing the overall quality of survey data. Additionally, once survey data has been collected,
cognitive testing results can provide useful information for users by documenting potential
IMPAQ International, LLC

14

OMB Supporting Statement

sources of response error as well as providing a richer understanding of the type of data that has
been collected.
Cognitive testing of the beneficiary questionnaire included conducting semi-structured
interviews using verbal probing techniques. Each interview consisted of two components: (1)
the interviewer administered the questionnaire and recorded the respondent’s answers, and (2)
after each question, the interviewer engaged the respondent in a conversation exploring the
meaning of the item and the respondent's answer.
The results of the cognitive test were not expected to be statistically significant due to the size of
the sample and the results will not be added to the full-scale data collection. Some of the main
findings of the pre-test are presented below:
About half of the participants did not perceive their complaint to be resolved.
Respondents may not differentiate between how long it took to resolve the complaint and
how the complaint was handled. It appears they are mainly concerned with the way the
complaint was handled.
Believing your complaint was resolved seems to be a driving factor in how participants
responded. The issue of resolution appears to set the tone in how satisfied the respondent
is with the overall process regardless of how long the resolution took or who they
perceived to resolve their complaint either Medicare or the contract.
Following the pre-test and receipt of public comments on the 60-Day Federal Register Notice,
CMS made changes to the questionnaire, which are summarized in OMB Supporting Statement
A (Section B.8.a. Federal Register Notice and Comments, Survey Instrument). However, the
survey instrument changes listed below are meant to highlight the changes that were principally
prompted by information from the pre-test and the comments of the nine participants:
General

In Q1, ―resolved‖ was replaced with ―settled.‖
In other questions, ―resolution‖ was replaced with ―final out come or
decision‖ to prevent beneficiary bias and to guide the beneficiary towards
the actions taken by the contract as opposed to the beneficiary's opinion of
the decision.

Q5

Question 5 has been removed from the survey. (CMS has decided to drop
questions about repeat complaints or multiple attempts to contact the
contract)

New question

Add question to assess beneficiary satisfaction with aspects of the complaint
handling process.
Beneficiaries will rate their satisfaction with
components of the handling process such as length of the complaint
process and courtesy of the contract representative. In a simplified form,

IMPAQ International, LLC

15

OMB Supporting Statement

this satisfaction question addresses issues from the original Q6 and Q8.
This question is now Q2 in the new survey instrument.
New question

Add question to identify survey respondent. This is a demographic
question to differentiate between respondent and proxy.
This question is now Q9 in the new survey instrument.

The changes that were made to the survey instrument were meant to clarify question wording
while improving beneficiary understanding and response quality.
The pre-test also revealed a significant incidence of beneficiaries who file complaints through a
representative or proxy. This issue was led to further analysis of complaints and CTM data to
quantify the expected proportion of affected complaints and to adequately prepare for this
population in the pilot test and full-scale data collections.
As the pre-test did not expose any insurmountable concerns, the survey instrument and data
collection methods were deemed acceptable for the study.
Pilot Test: After receipt of OMB approval, we will conduct a pilot test with approximately 100
beneficiaries in Q4 2010. The sample will be selected randomly following the proposed
sampling plan for the actual survey. The purpose of the pilot is to test the instrument on a
broader population, refine the data collection process, and produce preliminary measure statistics
– essentially, it is a dry run of all activities for the full-scale data collection. The pilot will also
allow testing for strategies to achieve reliable data and remove complaints that are not within the
contract’s domain. On issues of the data collection process, some of the testing will include:
Sending a pre-notification letter to sampled beneficiaries;
Loading sample information into the Computer-Assisted Telephone Interviewing (CATI)
system;
Administering the programmed instrument and ensuring that skip patterns are functioning
correctly;
Implementing the mail follow-up option for telephone nonrespondents;
Reviewing the data collected to make sure the questions are performing as intended under
real field conditions; and
Testing the preliminary performance measures and conducting exploratory and riskadjusted analyses.
Findings from the pilot test will be used to refine the data collection process to ensure seamless
implementation of the main survey. Both quantitative and qualitative analyses will be conducted
with pilot test data. These analyses will focus on two primary objectives: (1) identifying
IMPAQ International, LLC

16

OMB Supporting Statement

questions in the survey instrument that require refinements and (2) noting any necessary changes
to logistics and operations. Through qualitative analysis of open-ended questions, we will
determine the utility of these questions and also whether any closed-ended questions ought to be
added or modified to incorporate a common response or theme from beneficiary responses. Main
logistical issues that will be tracked include any difficulties with receiving data from CMS in real
time, timing of telephone and mailing communications with beneficiaries, and survey center
operations such as the issues raised by the interviewers or adjustments to the FAQs. In reviewing
these issue areas listed above, the pilot will be a test of all the aspects of the full-scale data
collection ensuring that the study will run smoothly in 2011.
The answers from the pilot will not be added to the survey results from the actual data collection.
At the end of the pilot test, we will submit a sample report reflecting the information collected
from the pilot test. This sample report will assist CMS in refining the reporting requirements.
5. Individuals Consulted on Statistical Methods
The following persons outside of CMS contributed to, reviewed, and/or approved the design,
instrumentation and sampling plan:
Affiliation

Telephone Number

Philippe Gwet

IMPAQ International

301-326-9001

Gongmei Yu

IMPAQ International

443-539-9769

Oswaldo Urdapilleta

IMPAQ International

202-289-0004 x503

Name

IMPAQ International, LLC

17

OMB Supporting Statement


File Typeapplication/pdf
AuthorJasmine Ainetchian
File Modified2010-09-03
File Created2010-09-03

© 2024 OMB.report | Privacy Policy